Oxysterol-based Antimicrobial Program

About Metaba

Metaba is an early-stage biotech targeting the global antimicrobial resistance (AMR) crisis with a novel oxysterol-based antibiotic platform. Originating from tuberculosis research, the company has expanded its scope to target other drug-resistant bacteria through hypothesis-driven metabolomic strategies. It is in the preclinical stage, building a leadership team with strong scientific and financial expertise, and actively engaging in partnerships and funding competitions to advance its pipeline.

Therapeutic Areas